Reply
We are grateful for Dr. Seto's letter, because he nicely highlighted the key message of our report by referring to the high rate of radial artery occlusions observed in our prospective registry as "a warning flag" to all transradial operators. It was not our intention to discourage transradial coronary procedures but rather to indicate the need to optimize post-interventional management by closely monitoring radial artery occlusion rates with Doppler ultrasound.
As discussed in our report (1) , there are probably 4 reasons to explain the higher-than-expected rate of radial artery occlusions (RAO):
1. Doppler ultrasound is more sensitive than clinical examination only in detecting RAO. We had several patients with retrograde radial artery pulse on clinical examination but RAO as confirmed by Doppler ultrasound. 2. The registry included consecutive patients after transradial procedures performed by both junior and senior staff in the catheterization laboratory-not just patients treated by radial experts-representing a real-world scenario. 3. Looking at the published data, it seems that administration of 5,000 IE rather than 2,500 IE of unfractionated heparin might reduce the RAO rate. In the early days of the transradial approach, Spaulding et al. (2) observed an RAO rate of 71% without heparin, 24.4% with 2,000 to 3,000 IE of heparin, and 4.3% with 5,000 IE of heparin. We increased the routine dose of heparin to 5,000 IE as a consequence of the registry. 
